Gsa Capital Partners LLP Amphastar Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 57,057 shares of AMPH stock, worth $1.73 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
57,057
Previous 45,297
25.96%
Holding current value
$1.73 Million
Previous $1.31 Million
0.23%
% of portfolio
0.09%
Previous 0.12%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
255Shares Held
32.4MCall Options Held
20.8KPut Options Held
11.9K-
Black Rock Inc. New York, NY5.94MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$81.5 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$61.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$49.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.6MShares$48.7 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.49B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...